FDA
approval
· 2025-11-25
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
The FDA approved a supplemental application for a generic irbesartan and hydrochlorothiazide fixed-dose combination tablet manufactured by Macleods Pharmaceutic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)